Title:
抗Ｌ１ＣＡＭ抗体及びその使用
Document Type and Number:
Japanese Patent JP2021529776
Kind Code:
A
Abstract:
本開示は、Ｌ１ＣＡＭに特異的に結合する抗体、及びかかる抗体を含む組成物を提供する。抗Ｌ１ＣＡＭ抗体を使用した、腫瘍を含む疾患または病態の予防または治療のための方法もまた、本明細書に提供される。【選択図】なし
Inventors:
Hong, Hyo Jung
Choi, His
Hong, Jisoo
Choi, His
Hong, Jisoo
Application Number:
JP2020573334A
Publication Date:
November 04, 2021
Filing Date:
June 27, 2019
Export Citation:
Assignee:
Apit Bio, Incorporated
International Classes:
C07K16/28; A61K35/12; A61K35/17; A61K39/395; A61K45/00; A61K47/68; A61K48/00; A61P1/04; A61P1/16; A61P1/18; A61P11/00; A61P13/08; A61P13/12; A61P15/00; A61P17/00; A61P21/00; A61P25/00; A61P35/00; A61P35/02; A61P43/00; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/13; C12N15/63; C12P21/08
Foreign References:
| US20150344571A1 | 2015-12-03 | |||
| WO2007114550A1 | 2007-10-11 | |||
| KR20100064985A | 2010-06-15 | |||
| KR20140026045A | 2014-03-05 |
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Previous Patent: Compound
Next Patent: Combination therapy with targeted TGF-β inhibition for the treatment of advanced non-small cell lun...
Next Patent: Combination therapy with targeted TGF-β inhibition for the treatment of advanced non-small cell lun...